OAC
WST icon

OMERS Administration Corp’s West Pharmaceutical WST Stock Holding History

OMERS Administration Corp’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.01M Buy
13,953
+1,184
+9% +$362K 0.03% 308
2026
Q1 		$3.2M Buy
12,769
+2,442
+24% +$608K 0.02% 384
2025
Q4 		$2.84M Buy
10,327
+7,684
+291% +$2.1M 0.02% 308
2025
Q3 		$693K Hold
2,643
– – 0.01% 652
2025
Q2 		$578K Hold
2,643
– – ﹤0.01% 625
2025
Q1 		$592K Sell
2,643
-435
-14% -$120K 0.01% 692
2024
Q4 		$1.01M Buy
3,078
+513
+20% +$161K 0.01% 525
2024
Q3 		$770K Hold
2,565
– – 0.01% 564
2024
Q2 		$845K Buy
+2,565
New +$906K 0.01% 569
2020
Q2 		– Sell
-3,500
Closed -$533K – 205
2020
Q1 		$533K Buy
+3,500
New +$539K 0.02% 121
2016
Q4 		– Sell
-2,900
Closed -$216K – 555
2016
Q3 		$216K Buy
+2,900
New +$230K ﹤0.01% 560

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

OMERS Administration Corp's WST Position: Q2 2026 in Review

OMERS Administration Corp increased its West Pharmaceutical (WST) stake by 9.3% in Q2 2026, buying an estimated $362K and bringing the position to 13,953 shares worth $5.01M. The position accounts for 0.03% of the portfolio, ranked #308.

OMERS Administration Corp first reported a position in WST in Q3 2016 and has held it in 11 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • OMERS Administration Corp held 13,953 shares of West Pharmaceutical worth $5.01M as of Q2 2026.
  • OMERS Administration Corp bought 1,184 West Pharmaceutical shares in Q2 2026, an estimated $362K.
  • West Pharmaceutical made up 0.03% of OMERS Administration Corp's portfolio in Q2 2026, its #308 holding.
  • OMERS Administration Corp first reported a position in West Pharmaceutical in Q3 2016 and has held it in 11 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.